HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 276, Issue 51, 47755-47758, December 21, 2001

This Article Abstract Full Text (PDF) All Versions of this Article: 276/51/47755    most recent C100587200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ward, I. M. Articles by Chen, J. Search for Related Content PubMed PubMed Citation Articles by Ward, I. M. Articles by Chen, J. Social Bookmarking                      What's this?

ACCELERATED PUBLICATION
Threonine 68 of Chk2 Is Phosphorylated at Sites of DNA Strand Breaks^*

Irene M. Ward, Xianglin Wu, and Junjie Chen^§

From the Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905

Received for publication, October 10, 2001

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

The protein kinase Chk2 has been implicated in signaling DNA damage to cell cycle checkpoints. In response to ionizing radiation, Chk2 becomes rapidly phosphorylated at threonine 68 by ataxia-telangiectasia mutated (ATM). Here we show that the Thr⁶⁸-phosphorylated form of Chk2 forms distinct nuclear foci in response to ionizing radiation. Only this activated form of Chk2 localizes at sites of DNA strand breaks. The kinase activity of Chk2 and the number of Chk2 foci formed depend on the severity of DNA damage and gradually decline correlating with the predicted value of slowly re-joining double strand breaks. These results suggest that Chk2 is regulated at the sites of DNA strand breaks in response to ionizing radiation.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Chk2 (Cds1), an evolutionary conserved protein kinase, is an important component of the DNA damage response pathway. Chk2/ ES cells are defective in maintaining ionizing radiation (IR)¹-induced G₂ arrest, and Chk2 null thymocytes fail to stabilize p53 and to induce G₁ arrest and apoptosis (1). Chk2 has also been reported to directly phosphorylate BRCA1 and to regulate its response to DNA damage (2). Moreover, heterozygous mutations in the Chk2 gene have been identified in a subset of patients with Li-Fraumeni syndrome (3), suggesting that Chk2 acts as a tumor suppressor.

The activation of Chk2 in response to DNA damage requires phosphorylation at threonine 68 (Thr⁶⁸) (4-7). Chk2T68 mutants show reduced Chk2 kinase activation and a diminished induction of the p53-dependent G₁ arrest in response to ionizing radiation (5, 6). The phosphorylation of Chk2 at Thr⁶⁸ in response to IR is ATM (ataxia-telangiectasia-mutated)-dependent, although an ATM-independent pathway exists in response to ultraviolet radiation (UV) and hydroxyurea (HU) treatment (4-7). However, little is known how Chk2 activation is initiated or how the activity of Chk2 is down-regulated following DNA repair. Given the physiological impact of the DNA damage pathway in genome stability and cancer prevention, it is necessary to gain a better understanding of the mechanisms underlying DNA damage signal transduction. Here we show that the Thr⁶⁸-phosphorylated form of Chk2 (Chk2T68P) forms distinct nuclear foci in response to ionizing radiation. Only this activated form localizes at sites of DNA strand breaks. The kinase activity of Chk2 and the number of Chk2 foci formed depend on the severity of DNA damage and gradually decrease with time. Together, our findings suggest that Chk2 activity is initiated and regulated at the sites of DNA strand breaks in response to ionizing radiation.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Constructs-- The plasmids for the expression of HA-tagged wild-type and kinase-inactive Chk2 were kindly provided by Dr. J. Sarkaria, Mayo Clinic. The T68A mutation was constructed using the QuikChange site-directed mutagenesis protocol (Stratagene).

Antibodies-- Rabbit and guinea pig polyclonal anti-Chk2T68P antibodies were raised against a peptide containing phosho-Thr⁶⁸ (CETVST(PO₄)QELYS). The antibodies were purified by affinity chromatography using the phospho-peptide linked to agarose beads (SulfoLink kit, Pierce) according to manufacturer's instructions. Antibodies for Chk2 were raised against GST fusion proteins containing full-length Chk2 (anti-Chk2 mAb#7) or the C-terminal residues 193-543 of Chk2 (anti-Chk2B). A mouse anti-53BP1 monoclonal antibody was raised against a mix of three GST fusion proteins encoding residues 1-337, 338-671, and 1331-1664 of 53BP1, respectively.

Immunoprecipitation and Western Blotting-- Cells were lysed in NETN buffer (150 mM NaCl, 1 mM EDTA, 20 mM Tris (pH 8), 0.5% Nonidet P-40) containing 1 mM phenylmethylsulfonyl fluoride for 20 min at 4 °C. Immunoprecipitation was carried out by incubating 4 mg of whole cell lysate with 1 µg of purified antibody and 20 µl of protein A-Sepharose beads (1:1) for 1 h at 4 °C. Beads were washed five times with NETN buffer. Bound proteins were eluted by boiling in SDS gel sample buffer, separated by SDS-PAGE, and transferred to Immobilon-P (Millipore). The polyvinylidene difluoride membrane was blocked with 5% nonfat milk for 30 min and incubated with 2 µg/ml anti-Chk2T68P or a 1:10 dilution of anti-Chk2mAb#7 for 1 h. Horseradish peroxidase-conjugated protein A (Amersham Pharmacia Biotech) or rabbit anti-mouse IgG were used as secondary antibodies. Immunoblotted proteins were visualized by chemiluminescence using the Supersignal kit purchased from Pierce.

In Vitro Kinase Assay-- Immunoprecipitated Chk2 was incubated with or without 1 µg of purified GST-Cdc25C (residues 200-256) for 30 min at 30 °C in 25 µl of kinase buffer (50 mM Tris (pH 7.5), 10 mM MgCl₂), including 10 µM ATP and 10 µCi of [-³²P]ATP. The reactions were stopped by the addition of 25 µl 2× Laemmli buffer. The samples were separated on a 12% SDS-PAGE, dried, and visualized by autoradiography.

Immunostaining-- Cells grown on coverslips were fixed for 10 min in phosphate-buffered saline-buffered 3% paraformaldehyde, 2% sucrose solution and permeablized for 5 min in ice-cold Triton buffer (0.5% Triton X-100 in 20 mM HEPES (pH 7.4), 50 mM NaCl, 3 mM MgCl₂, 300 mM sucrose). In case of anti-NBS1 staining, a 1:1 methanol:acetone solution was used to fix and permeabilize the cells. Immunostaining was performed using anti-Chk2 mAb#7 at a dilution of 1:10 or anti-Chk2T68P serum at a concentration of 0.35 µg/ml in 5% goat serum. Anti-53BP1 hybridoma supernatant (BP13) was used at a dilution of 1:30 and anti-NBS1 antibody (kindly provided by Dr. X. Wu, Dana Farber Cancer Institute) at a dilution of 1:5. The cells were incubated with the primary antibodies for 20 min at 37 °C, washed, and incubated with a fluorescein isothiocyanate-conjugated goat anti-mouse and/or rhodamine-conjugated goat anti-rabbit secondary antibody (Jackson ImmunoResearch Laboratory, Inc.) at 1 to 200 dilution for 15 min. Cells were counterstained with Hoechst dye for 1 min. After mounting, the cells were viewed with a Nikon ECLIPSE E800 fluorescence microscope using a 60× objective, and images were processed using Adobe Photoshop and Canvas software.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Phosphorylation and Activation of Chk2 Depend on the Severity of DNA Damage-- To investigate the phosphorylation and activation of Chk2, we raised polyclonal anti-phospho-Thr⁶⁸ antibodies against a Chk2 peptide containing T68P (CETVST(PO₄)QELYS). The specificity of these affinity-purified antibodies was examined by Western blot analysis. HA-tagged wild-type, a T68A mutant, or a kinase-inactive mutant (D347A) of Chk2 were transiently expressed in U2OS cells. Anti-HA immunoprecipitates from lysates isolated from -irradiated, transiently transfected U2OS cells were imunoblotted with either anti-Chk2 (raised against GST fusion proteins containing full-length Chk2) or anti-Chk2T68P antibodies. As shown in Fig. 1A (left panel), whereas Chk2 was equally detected in all samples, the anti-Chk2 T68P antibodies specifically recognized the phosphorylated wild-type Chk2, but not the T68A mutant protein.

View larger version (48K): [in this window] [in a new window]   Fig. 1.   Phosphorylation and activation of Chk2 depend on the severity of DNA damage. A, left panel: HA-tagged wild-type or T68A mutated Chk2 proteins were immunoprecipitated from transiently transfected U2OS cells before and 1 h after 5 Gy of IR. Right panel: whole cell extracts were prepared from 293T cells before and 1 h after the indicated doses of radiation. Western blots were performed using anti-Chk2 or anti-Chk2T68P antibodies. B, left panel: Chk2 immunoprecipitates were prepared from HeLa cells before and 1 h after treatment with HU (10 mM), CPT (1 µM), or 5 Gy of IR. 5 and 45% of the immunoprecipitates were separated on a SDS-PAGE and blotted with anti-Chk2 or anti-Chk2T68P antibody, respectively. The remaining immunoprecipitate was used to perform kinase reactions using GST-Cdc25C as a substrate. Right panel: Chk2T68 is predominantly phosphorylated by ATM. FT169A (ATM/) cells and the ATM-wild-type reconstituted derivative cell line YZ5 were irradiated with 5 Gy and harvested before or 160 min after IR. Immunoblots and kinase assays were performed as described above. C, Chk2 was immunoprecipitated from HeLa cells 1 h after 0, 1, or 5 Gy of IR or 10-160 min after 1 Gy of IR as indicated. Cell extracts were processed as described above.

To further confirm that these antibodies only recognize phospho-Chk2 following DNA damage, we performed Western blot analysis using whole cell extracts prepared from 293T cells before and after exposure to 2-25 Gy of ionizing radiation. Whereas the anti-Chk2 antibodies detected equal amounts of total Chk2 in the various irradiated and non-irradiated samples, the anti-Chk2T68P antibodies recognized the phosphorylated Chk2 as a single ~70-kDa band in the irradiated samples (Fig. 1A, right panel). The intensity of this band increased with the radiation doses.

We then immunoprecipitated endogenous Chk2 from HeLa cell lysates prepared before and after treatments with HU, camptothecin (CPT), or IR. Whereas Chk2 protein levels did not change in response to various treatments, phosphorylation of Chk2T68 was only detected following exposure to IR or treatment with the topoisomerase I poison CPT, both of which induce DNA strand breaks (Fig. 1B, left panel). In agreement with the early finding that Thr⁶⁸ phosphorylation is important for Chk2 activation (4-6), the kinase activities of Chk2, measured by autophosphorylation of Chk2 and phosphorylation of GST-Cdc25C (residues 200-256), increased following IR and CPT treatment (Fig. 1B, left panel). In contrast, only a slight increase in the phosphorylation of Chk2T68 was detected after a 1-h treatment with HU (Fig. 1B, left panel). Consistent with a role of ATM in the phosphorylation of Chk2, Thr⁶⁸ phosphorylation and Chk2 activation were not detected in ATM-deficient FT169A cells after IR, while Chk2 was phosphorylated and activated in the isogenic, wild-type ATM-reconstituted YZ5 cells (Fig. 1B, right panel).

Increasing doses of -radiation resulted in increased levels of Chk2T68 phosphorylation (Fig. 1A, right panel; Fig. 1C, left panel) and a corresponding increase in Chk2 kinase activity (Fig. 1C, left panel). To examine the time course of Chk2 phosphorylation and activation, we irradiated HeLa cells with 5 Gy of IR and prepared lysates at various time points (0-160 min) after radiation. While the level of total Chk2 did not change over time, Chk2T68P increased in the first 20 min after radiation and then gradually decreased (Fig. 1C, right panel). A similar time course was observed for Chk2 kinase activities, as measured by Chk2 autophosphorylation and its ability to phosphorylate GST-Cdc25C (Fig. 1C, right panel). Taken together, these results suggest that the phosphorylation and activation of Chk2 correlate with the severity of DNA damage. Furthermore, dephosphorylation and inactivation of Chk2 correlate with the reported time course of DNA repair (8, 9).

Chk2T68P Forms Nuclear Foci in Response to IR-- We next examined the subcellular distribution of Chk2 or Chk2T68P by indirect immunofluorescent analysis. The majority of Chk2 showed a diffuse nuclear staining pattern that did not appear to change upon exposure to IR (Fig. 2A). Whereas little or no Chk2T68P was detected in un-irradiated HeLa cells, distinct nuclear foci of Chk2T68P were observed following IR (Fig. 2A). The number of Chk2T68P foci increased in a dose-dependent fashion (Fig. 2A and data not shown) corresponding to the increase in Chk2T68 phosphorylation observed by Western analysis (Fig. 1C). Since the phosphorylation of Chk2 at Thr⁶⁸ is predominantly dependent on ATM following IR (Refs. 4-7 and Fig. 1C), we examined Chk2T68P foci formation in wild-type versus ATM-deficient cells. While Chk2T68P foci formed readily in ATM+ YZ5 cells (Fig. 2B and data not shown), foci formation was greatly reduced in the isogenic ATM-deficient FT169A cells (Fig. 2B). In addition, pretreatment of HeLa cells with wortmannin, a fungal metabolite that inhibits phosphatidylinositol 3-OH-kinase-related kinases including ATM, blocked the formation of radiation-induced Chk2T68P foci (Fig. 2C).

View larger version (41K): [in this window] [in a new window]   Fig. 2.   Chk2T68P forms nuclear foci in response to IR. A, HeLa cells were immunostained with anti-Chk2 and anti-Chk2T68P antibodies before and after exposure to 0, 1, or 5 Gy of IR. B, ATM+ (YZ25) and ATM/ (FT169A) cells were irradiated with 0 or 2 Gy and immunostained with anti-Chk2T68P 20 min or 160 min later. C, HeLa cells were pretreated with 0 or 50 µM wortmannin for 30 min prior to exposure to 1 Gy of IR. After recovery for 1 h, the control or irradiated cells were immunostained with anti-Chk2T68P antibodies.

Chk2T68P Co-localizes with 53BP1, -H2AX, and NBS1-- The rapid, dose-dependent phosphorylation and activation of Chk2 in nuclear foci is reminescent of the IR-induced phosphorylation of histone H2AX. Phosphorylated H2AX (-H2AX) forms distinct foci at sites of DNA strand breaks in response to DNA damage (10, 11). We (12) and others (13) have previously shown that 53BP1 rapidly co-localizes with -H2AX at the sites of DNA strand breaks following IR. To examine whether phosphorylated Chk2 localizes at the sites of DNA strand breaks, we performed co-immunostaining experiments using anti-Chk2T68P and anti-53BP1 or anti--H2AX antibodies. As shown in Fig. 3A, Chk2T68P foci overlapped with 53BP1 foci 1 h after exposure to 1 Gy of radiation. Similar staining patterns were also observed following CPT treatment (Fig. 3A), while short term treatment (1 h) with HU, which induced only a weak phosphorylation of Chk2T68 (Fig. 1B, left panel), did not lead to significant Chk2T68P foci formation (Fig. 3A). Co-immunostaining with anti--H2AX confirmed that Chk2T68P foci localize at DNA strand breaks in response to IR (Fig. 3B and data not shown). As shown by earlier studies (10, 13) NBS1 co-localizes with -H2AX and 53BP1 several hours after IR. Likewise, NBS1 also co-localized with Chk2T68P in these late, IR-induced foci (Fig. 3C).

View larger version (54K): [in this window] [in a new window]   Fig. 3.   Chk2T68P co-localizes with 53BP1, -H2AX, and NBS1. A, HeLa cells were co-immunostained with anti-Chk2T68P and anti-53BP1 antibodies before and 1 h after exposure to 1 Gy of IR, 1 µM CPT, or 10 mM HU. B, HeLa cells were co-immunostained with guinea pig anti-Chk2T68P antibodies and rabbit anti-phospho-H2AX antibodies before and 10 min after 1 Gy of IR. C, HeLa cells were co-immunostained with anti-Chk2T68P and anti-NBS1 antibodies before and 15 h after exposure to 10 Gy of IR.

Time Course of Chk2T68 Foci Formation-- Time course studies revealed that the phosphorylated form of Chk2 co-localized with 53BP1 within 10 min following IR and remained co-localized over the entire time interval tested (i.e. 10-160 min after IR; Fig. 4). Similar to -H2AX and 53BP1, the Chk2T68P foci number increased during the first 30 min and then gradually decreased thereafter. This decrease in the Chk2T68P foci number correlates with the decreases in the phosphorylation and kinase activity of Chk2 (Fig. 1C), suggesting that Chk2 may be dephosphorylated and inactivated at these DNA damage sites after DNA repair is accomplished.

View larger version (70K): [in this window] [in a new window]   Fig. 4.   The time course of Chk2T68 foci formation and disappearance coincides with that of 53BP1. HeLa cells were subjected to 1 Gy of IR and co-immunostained with anti-Chk2T68P and anti-53BP1 antibodies before or at various time points after irradiation (10-60 min as indicated).

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Our data show that phosphorylation and activation of Chk2 by ATM correlate with the severity of DNA damage in vivo. The activated form of Chk2 localizes in distinct foci at the sites of DNA strand breaks within minutes following ionizing radiation. The disappearance of these foci coincides with that of -H2AX and 53BP1 and correlates with the reported time course of DNA repair (8, 9, 11, 12). The phosphorylation and activation of Chk2 by ATM occurs most likely at the sites of DNA breaks. First, ATM can be directly activated by DNA breaks in vitro (14, 15). Second, following DNA damage, ATM co-localizes with -H2AX foci in vivo (16). It is not yet known whether ATM directly phosphorylates Chk2 or this phosphorylation event requires a mediator. In budding yeast, phosphorylation and activation of the Chk2 homologue scRad53 by Mec1, an ATM homologue, require scRad9, a protein with C-terminal tandem BRCT motifs (BRCA1 C-terminus). It is intriguing that phosphorylated Chk2 co-localizes with 53BP1, a protein also containing C-terminal tandem BRCT motifs. It remains to be determined whether the phosphorylation and activation of Chk2 requires 53BP1 in mammals.

The phosphorylation of Chk2 at Thr⁶⁸ does not correlate with the ATM-dependent mobility shift of Chk2 following ionizing radiation. While Chk2T68 phosphorylation is rapid and transient (see Fig. 1C), the mobility shift-associated hyperphosphorylation of Chk2 appears to be gradual and persists at least 24-48 h following DNA damage (17). Indeed, a Chk2T68A mutant, which cannot be phosphorylated at Thr⁶⁸ and is defective in activation following DNA damage, still shows the same mobility shift on SDS-PAGE as wild-type Chk2 (5). Thus, the mobility shift-associated hyperphosphorylation of Chk2 depends largely on the phosphorylation of sites distinct from Thr⁶⁸. While Thr⁶⁸ phosphorylation of Chk2 correlates with the activation of Chk2 (4-7), the function of this mobility shift-associated hyperphosphorylation of Chk2 remains to be solved. One possibility is that this mobility shift-associated hyperphosphorylation of Chk2 represents a certain negative feedback mechanism. Such complex regulation of kinase activity by various phosphorylation events has been documented for Raf-1 protein kinase. While Raf-1 is initially activated by specific phosphorylation events, the subsequent mobility shift-associated hyperphosphorylation of Raf-1 down-regulates Raf-1 activity and represents a negative feedback mechanism contributing to the desensitization of the signaling pathway (for example, see Ref. 18). Similar feedback mechanism may exist for Chk2 in the DNA damage-signaling pathway.

	ACKNOWLEDGEMENTS

We thank Drs. Scott Kaufmann, Larry Karnitz, and Jann Sarkaria for stimulating conversations and members of Dr. Junjie Chen's laboratory for helpful discussions.

	FOOTNOTES

^* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

These authors contributed equally to the work.

^§ To whom correspondence should be addressed: Guggenheim 1342, Division of Oncology Research, Mayo Clinic, 200 First St., S.W., Rochester, MN 55905. Fax: 507-284-3906; E-mail: Chen.junjie@mayo.edu.

Published, JBC Papers in Press, October 19, 2001, DOI 10.1074/jbc.C100587200

	ABBREVIATIONS

The abbreviations used are: IR, ionizing radiation; ATM, ataxia-telangiectasia-mutated; HU, hydroxyurea; GST, glutathione S-transferase; PAGE, polyacrylamide gel electrophoresis; HA, hemagglutinin; Gy, gray; CPT, camptothecin.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				A. Yoda, K. Toyoshima, Y. Watanabe, N. Onishi, Y. Hazaka, Y. Tsukuda, J. Tsukada, T. Kondo, Y. Tanaka, and Y. Minami Arsenic Trioxide Augments Chk2/p53-mediated Apoptosis by Inhibiting Oncogenic Wip1 Phosphatase J. Biol. Chem., July 4, 2008; 283(27): 18969 - 18979. [Abstract] [Full Text] [PDF]

				A. Yoda, X. Z. Xu, N. Onishi, K. Toyoshima, H. Fujimoto, N. Kato, I. Oishi, T. Kondo, and Y. Minami Intrinsic Kinase Activity and SQ/TQ Domain of Chk2 Kinase as Well as N-terminal Domain of Wip1 Phosphatase Are Required for Regulation of Chk2 by Wip1 J. Biol. Chem., August 25, 2006; 281(34): 24847 - 24862. [Abstract] [Full Text] [PDF]

				M. Cuadrado, B. Martinez-Pastor, M. Murga, L. I. Toledo, P. Gutierrez-Martinez, E. Lopez, and O. Fernandez-Capetillo ATM regulates ATR chromatin loading in response to DNA double-strand breaks J. Exp. Med., February 21, 2006; 203(2): 297 - 303. [Abstract] [Full Text] [PDF]

				H.-C. Wang, W.-C. Chou, S.-Y. Shieh, and C.-Y. Shen Ataxia Telangiectasia Mutated and Checkpoint Kinase 2 Regulate BRCA1 to Promote the Fidelity of DNA End-Joining Cancer Res., February 1, 2006; 66(3): 1391 - 1400. [Abstract] [Full Text] [PDF]

				J.-E. Kim, S. A. McAvoy, D. I. Smith, and J. Chen Human TopBP1 Ensures Genome Integrity during Normal S Phase Mol. Cell. Biol., December 15, 2005; 25(24): 10907 - 10915. [Abstract] [Full Text] [PDF]

				J. Li and D. F. Stern DNA Damage Regulates Chk2 Association with Chromatin J. Biol. Chem., November 11, 2005; 280(45): 37948 - 37956. [Abstract] [Full Text] [PDF]

				P. R. Potts and H. Yu Human MMS21/NSE2 Is a SUMO Ligase Required for DNA Repair Mol. Cell. Biol., August 15, 2005; 25(16): 7021 - 7032. [Abstract] [Full Text] [PDF]

				J.-H. Wei, Y.-F. Chou, Y.-H. Ou, Y.-H. Yeh, S.-W. Tyan, T.-P. Sun, C.-Y. Shen, and S.-Y. Shieh TTK/hMps1 Participates in the Regulation of DNA Damage Checkpoint Response by Phosphorylating CHK2 on Threonine 68 J. Biol. Chem., March 4, 2005; 280(9): 7748 - 7757. [Abstract] [Full Text] [PDF]

				S.-J. Lee, J. K. Duong, and D. F. Stern A Ddc2-Rad53 Fusion Protein Can Bypass the Requirements for RAD9 and MRC1 in Rad53 Activation Mol. Biol. Cell, December 1, 2004; 15(12): 5443 - 5455. [Abstract] [Full Text] [PDF]

				M. T. Jack, R. A. Woo, N. Motoyama, H. Takai, and P. W. K. Lee DNA-dependent Protein Kinase and Checkpoint Kinase 2 Synergistically Activate a Latent Population of p53 upon DNA Damage J. Biol. Chem., April 9, 2004; 279(15): 15269 - 15273. [Abstract] [Full Text] [PDF]

				S. J. H. Arlander, A. K. Eapen, B. T. Vroman, R. J. McDonald, D. O. Toft, and L. M. Karnitz Hsp90 Inhibition Depletes Chk1 and Sensitizes Tumor Cells to Replication Stress J. Biol. Chem., December 26, 2003; 278(52): 52572 - 52577. [Abstract] [Full Text] [PDF]

				X. Wu and J. Chen Autophosphorylation of Checkpoint Kinase 2 at Serine 516 Is Required for Radiation-induced Apoptosis J. Biol. Chem., September 19, 2003; 278(38): 36163 - 36168. [Abstract] [Full Text] [PDF]

				I. Louria-Hayon, T. Grossman, R. V. Sionov, O. Alsheich, P. P. Pandolfi, and Y. Haupt The Promyelocytic Leukemia Protein Protects p53 from Mdm2-mediated Inhibition and Degradation J. Biol. Chem., August 29, 2003; 278(35): 33134 - 33141. [Abstract] [Full Text] [PDF]

				C. C. S. Chini and J. Chen Human Claspin Is Required for Replication Checkpoint Control J. Biol. Chem., August 8, 2003; 278(32): 30057 - 30062. [Abstract] [Full Text] [PDF]

				P. Roos-Mattjus, K. M. Hopkins, A. J. Oestreich, B. T. Vroman, K. L. Johnson, S. Naylor, H. B. Lieberman, and L. M. Karnitz Phosphorylation of Human Rad9 Is Required for Genotoxin-activated Checkpoint Signaling J. Biol. Chem., June 27, 2003; 278(27): 24428 - 24437. [Abstract] [Full Text] [PDF]

				J. K. Schwarz, C. M. Lovly, and H. Piwnica-Worms Regulation of the Chk2 Protein Kinase by Oligomerization-Mediated cis- and trans-Phosphorylation Mol. Cancer Res., June 1, 2003; 1(8): 598 - 609. [Abstract] [Full Text] [PDF]

				Z. Lou, C. C. S. Chini, K. Minter-Dykhouse, and J. Chen Mediator of DNA Damage Checkpoint Protein 1 Regulates BRCA1 Localization and Phosphorylation in DNA Damage Checkpoint Control J. Biol. Chem., April 11, 2003; 278(16): 13599 - 13602. [Abstract] [Full Text] [PDF]

				I. M. Ward, K. Minn, J. van Deursen, and J. Chen p53 Binding Protein 53BP1 Is Required for DNA Damage Responses and Tumor Suppression in Mice Mol. Cell. Biol., April 1, 2003; 23(7): 2556 - 2563. [Abstract] [Full Text] [PDF]

				L. Tsvetkov, X. Xu, J. Li, and D. F. Stern Polo-like Kinase 1 and Chk2 Interact and Co-localize to Centrosomes and the Midbody J. Biol. Chem., February 28, 2003; 278(10): 8468 - 8475. [Abstract] [Full Text] [PDF]

				X. Xu and D. F. Stern NFBD1/KIAA0170 Is a Chromatin-associated Protein Involved in DNA Damage Signaling Pathways J. Biol. Chem., February 28, 2003; 278(10): 8795 - 8803. [Abstract] [Full Text] [PDF]

				Y. L. Shang, A. J. Bodero, and P.-L. Chen NFBD1, a Novel Nuclear Protein with Signature Motifs of FHA and BRCT, and an Internal 41-Amino Acid Repeat Sequence, Is an Early Participant in DNA Damage Response J. Biol. Chem., February 14, 2003; 278(8): 6323 - 6329. [Abstract] [Full Text] [PDF]

				J. Ahn and C. Prives Checkpoint Kinase 2 (Chk2) Monomers or Dimers Phosphorylate Cdc25C after DNA Damage Regardless of Threonine 68 Phosphorylation J. Biol. Chem., December 6, 2002; 277(50): 48418 - 48426. [Abstract] [Full Text] [PDF]

				B. Wang, S. Matsuoka, P. B. Carpenter, and S. J. Elledge 53BP1, a Mediator of the DNA Damage Checkpoint Science, November 15, 2002; 298(5597): 1435 - 1438. [Abstract] [Full Text] [PDF]

				P. Roos-Mattjus, B. T. Vroman, M. A. Burtelow, M. Rauen, A. K. Eapen, and L. M. Karnitz Genotoxin-induced Rad9-Hus1-Rad1 (9-1-1) Chromatin Association Is an Early Checkpoint Signaling Event J. Biol. Chem., November 8, 2002; 277(46): 43809 - 43812. [Abstract] [Full Text] [PDF]

				M. T. Jack, R. A. Woo, A. Hirao, A. Cheung, T. W. Mak, and P. W. K. Lee Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response PNAS, July 23, 2002; 99(15): 9825 - 9829. [Abstract] [Full Text] [PDF]

				X. Xu, L. M. Tsvetkov, and D. F. Stern Chk2 Activation and Phosphorylation-Dependent Oligomerization Mol. Cell. Biol., June 15, 2002; 22(12): 4419 - 4432. [Abstract] [Full Text] [PDF]

				J.-Y. Ahn, X. Li, H. L. Davis, and C. E. Canman Phosphorylation of Threonine 68 Promotes Oligomerization and Autophosphorylation of the Chk2 Protein Kinase via the Forkhead-associated Domain J. Biol. Chem., May 24, 2002; 277(22): 19389 - 19395. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 276/51/47755    most recent C100587200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire